Rod Wong joins Stephanie Sirota to trace biotech's evolution. What forces built today’s innovation landscape, and what might the next decade reveal?

PODCAST TEAM

Producer & Director: Devon Leaver

Editor: Dominique Guerra

Production Coordinator: YingYu Lin

Production Support: Annabelle Chan

Theme music: Ganymede by Yehezkel Raz

Additional music: APM Music

Featuring: Rod Wong, Managing Partner and Chief Investment Officer at RTW Investments, moderated by Stephanie A. Sirota, Partner, Chief Business Officer at RTW Investments.

FOLLOW US

Love our podcast? Follow us on LinkedIn at RTW Investments, LP and check out our website for the latest updates and insights.

To make sure you never miss an episode, you can subscribe to the RTW podcast on YouTube, Spotify, Apple Podcasts, Amazon Music, and most other podcast platforms.

Learn more about 'Innovation is the Best Medicine' here.

CHAPTERS

00:00 – Introduction

1:22 – Gene therapy and biotech

4:51 – Rod Wong’s journey into biotech

9:55 – Rod Wong: Investor or Business Builder?

12:43 – Growing trends in biotechnology

15:36 – Generating Alpha in Biotech

21:54 – Looking forward for RTW

23:51 - Outro

DISCLAIMER

This interview was given by Rod Wong, Managing Partner and Chief Investment Officer at RTW Investments, and moderated by Stephanie A. Sirota, Partner, Chief Business Officer at RTW Investments. Statements reflect RTW's views and opinions as of the date hereof and not as of any future date. All expressions of opinion are subject to change without notice and are not intended to be a forecast of future events or results. The views expressed by guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent.